Navigation Links
Barbra Streisand endows program at Cedars-Sinai women's heart center

LOS ANGELES (April 16, 2008) A bold new resource for womens heart health, The Barbra Streisand Womens Cardiovascular Research and Education Program at Cedars-Sinai, has been created with a philanthropic gift of $5 million. The gift brings to nearly $16 million the money raised from her recent concert tours she has directed to charitable distribution in the areas of education, the environment, womens health, and other key civic concerns.

Cardiovascular disease is the leading killer of women, says Eduardo Marbn, MD, PhD, director at the Cedars-Sinai Heart Institute. It kills nearly 500,000 women in the U.S. each year, more than all cancers combined. The medical system has failed to recognize female-pattern heart attack symptoms; current testing and treatments are geared toward male physiology.

Ms. Streisand, who has contributed to womens health programs through the Streisand Foundation since 1986, explained: Women need to be educated about female cardiovascular disease, and the medical community must be propelled toward change. Just like with breast cancer, the impetus must come from women themselves striving to become empowered to reduce their risks for heart disease.

Streisands endowment will provide permanent funding for research and education at the Cedars-Sinai Womens Heart Center, which will empower women with vital information about female cardiovascular disease and raise awareness of the disease within the medical community. It will expand current and future research efforts and create breakthrough diagnostics, treatments and technologies. It will facilitate better understanding of gender differences in heart disease, with the aim of improving treatment options for women at risk for, or suffering from heart disease.

The endowment supports the work of C. Noel Bairey Merz, MD, director of the Womens Heart Center at Cedars-Sinai and holder of the Womens Guild Chair in Womens Health and is organized around the five frontiers of womens cardiovascular research:

  • Ending cardiac death in women through early detection

  • Advancing new treatments for microvascular coronary dysfunction, an often deadly disorder primarily affecting women

  • Identifying gender-specific genes and proteins that increase or reduce the risk of heart disease in women

  • Conducting clinical trials of promising new drugs for women

  • Understanding how to harness nutrition, exercise, and stress management to reduce heart disease in women

Even physicians do not fully appreciate the degree to which women are at risk for heart disease. Most are insufficiently aware that a woman having a heart attack is 20 percent more likely to die from it than a man. Dr. Bairey Merz urges that It must become a top priority on the national medical agenda to make testing, diagnosis and treatments more relevant to female physiology. We are thrilled Ms. Streisand has chosen to make womens heart health a priority of her philanthropic giving. She goes on to explain: As an endowment, funding for the dissemination of education -- both among women and within the medical community -- and research into relevant testing and treatments can continue, not just for the immediate future, but for generations to come.


Contact: Janet Keller
Cedars-Sinai Medical Center

Related medicine news :

1. John Hancocks EZ Route Post-Enrollment Education Program Wins 2008 Insight Award for Customer Advocacy in Financial Services
2. Nations Vending Industry Unveils New Health Oriented Vending Program:
3. Video: National Association of School Nurses Launches Educational Program to Address Surge of Prescription Drug Abuse by Americas Youth
4. Brandes Proposes 130 yen per Share Dividend and 10 Million Share Buyback Program for Ono Pharmaceutical Annual Meeting
5. Draft National Toxicology Program Report Supports Safety of Bisphenol A
6. Palmetto GBA Ranked Among Nations Best for Ethics, Compliance Programs
7. Precyse Solutions Launches Clinical Documentation Improvement Program to Assist Hospitals in Accelerating Revenues
8. Intronis Technologies eSureIT Partner Program Certified Gold By CMP Channels VARBusiness
9. At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
10. McCarty Cancer Foundation Awards $50,000 Grant for Myeloma Research Program at Karmanos Cancer Institute
11. New Montefiore Program Targets Elder Abuse and Neglect
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... ... Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as ... Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center marketplace. ...
(Date:11/30/2015)... ... ... Trevor and Taylor Crabb have unveiled an exciting new campaign to unite ... States. This hybrid crowdfunding campaign is designed to provide the Crabb brothers’ ... offering corporate sponsors with some great marketing deliverables with the brothers for the 2016 ...
(Date:11/30/2015)... ... ... The National Association of Professional Women (NAPW) honors Dawn ... She is recognized with this prestigious distinction for leadership in estate sales and moving. ... 850,000 members and over 200 operating Local Chapters. , “I’m pleased to welcome Dawn ...
(Date:11/30/2015)... ... December 01, 2015 , ... ... to offer individual vision insurance plans on . The multi-carrier insurance ... rate and review products, allowing consumers to compare, quote and match plans to ...
(Date:11/30/2015)... ... November 30, 2015 , ... During the National ... caregivers and held two webinars on topics of ‘Medical and Palliative Care Decisions,’ ... at . , With a loved one's diagnosis of mesothelioma, the ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)...  QT Vascular Ltd., together with its subsidiaries (the ... TriReme Medical LLC and Quattro Vascular Pte. Ltd., collectively ... assembly and distribution of advanced therapeutic solutions for the ... announce that a three-judge panel of the ... Federal Circuit ("Federal Circuit") has unanimously granted the Group ...
(Date:11/30/2015)... ) has ... Market 2015-2019" report to their offering. ... of the "Orphan Drugs Market 2015-2019" ... and Markets ( ) has announced the ... report to their offering. ...
(Date:11/30/2015)... -- IBA Molecular North America, Inc. (IBAMNA), a U.S. leader ... as of January 1, 2016, it will do business ... rebrand the company reflects a refined vision for the ... relationship with Zevacor Molecular.  Both IBAMNA and Zevacor Molecular ... Peter Burke , Vice President Sales and ...
Breaking Medicine Technology: